분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2013-05-22 10:15:19 , Hit : 2946
 Viruses in the gut protect from infection


Phages in mucus aid immune system by killing invading bacteria.

Ed Yong 20 May 2013

ExpandViruses known as bacteriophages, seen here attacking an E. coli (in a coloured scanning electron micrograph), abound in the mucus of organisms across the animal kingdom, where they help keep bacteria in check.

JUERGEN BERGER/SCIENCE PHOTO LIBRARY
Article toolsPrint


“Mucus is everywhere,” says microbiologist Jeremy Barr. Almost every animal uses it to make a barrier that protects tissues that are exposed to the environment, such as the gut or lungs. Now, Barr and a team of researchers have discovered that mucus is also the key to an ancient partnership between animals and viruses.

Barr and his colleagues, who are based at San Diego State University in California, show that animal mucus — whether from humans, fish or corals — is loaded with bacteria-killing viruses called phages. These protect their hosts from infection by destroying incoming bacteria. In return, the phages are exposed to a steady torrent of microbes in which to reproduce. “It’s a unique form of symbiosis, between animals and viruses,” says Rotem Sorek, a microbial geneticist at the Weizmann Institute of Science in Rehovot, Israel, who was not involved in the research.

“It’s groundbreaking,” adds Frederic Bushman, a microbiologist from the University of Pennsylvania in Philadelphia. “The idea that phage can be viewed as part of the innate immune system is original and exciting.” The results are published in the Proceedings of the National Academy of Sciences1.


The study’s leader, microbial ecologist Forest Rohwer, has been collecting mucus from across the animal kingdom for years, and noticed that these samples contained over four times more phages than the surrounding environment. “One of the most exciting aspects about this symbiotic relationship is that it likely acts at all mucus surfaces, and has been evolving ever since mucus was first produced,” says Barr.

Sticky bottlebrush
Mucus mainly consists of huge molecular complexes called mucins, which are made up of thousands of glycan sugars attached to a central protein backbone. The team showed that phages stick to these sugars, which Barr likens to a “large biological bottlebrush”.

The glycans are constantly changing and extremely variable, but the phages have equally diverse proteins in their coats, which allow them to cling to this inconsistent environment. The team showed that the presence of phages reduced the number of bacteria that can attach to mucus by more than 10,000 times.

Barr says he thinks that the phage strains found most often in mucus will be those that target the most common bacteria, providing a sort of 'mucus memory' against the most relevant local microbes. But because mucus is continuously being shed and replenished, these relationships are in constant flux. Barr, Rohwer and the team are now trying to simulate the evolutionary dynamics within this realm of mucus.

The researchers are also exploring the implications for human health. For example, Barr wonders if one could deliberately coat an individual’s gut with mucus-bound phages that are specifically directed against disease-causing bacteria. “This may provide an increased basal level of immunity against such infections,” he says.

Sorek adds that, in the past few years, scientists have started to appreciate how common phages are in the gut and how they influence human health by shaping the resident microbe communities. He wants to know if animals can recruit mucus-bound phages in a “smart” way, to select for beneficial bacteria over those that cause disease.

Barr thinks that this might be so. He notes that phages sometimes insert their genetic material into a bacterium’s genome rather than killing it outright — a process that can actually protect the bacterium against other phages. Barr speculates that in this way, mucus-borne phages might protect bacteria that benefit their animal hosts, while destroying those that cause harm.

Journal name:
Nature
DOI:
doi:10.1038/nature.2013.13023
References
Barr, J. J. et al. Proc. Natl. Acad. Sci. USA http://dx.doi.org/10.1073/pnas.1305923110 (2013).








787   Gene Editing Treats Blood Disease  이성욱 2011/07/16 3065
786   A pathogenic picornavirus acquires an envelope by hijacking cellular membranes  이성욱 2013/04/23 3056
785   The Sugar Lnc  이성욱 2012/05/10 3035
784   A targeted cancer therapy? - small conditional RNA  이성욱 2010/09/08 3021
783   More support for transcription trickPosted by Jef Akst  이성욱 2010/05/01 3003
782   Roche hepatitis C drug appears safe in combination  이성욱 2010/10/17 3001
781   면역 시스템을 가지는 바이러스  이성욱 2013/03/01 2992
780   유전자 특허 불인정 판결의 후폭풍: 멘붕에 빠진 미 BT 업계  이성욱 2013/06/20 2983
779   배아 발달 동안 돌연변이와 성인에서 암 발병 관련성  이성욱 2012/06/18 2981
778   Hepatitis C Virus Infection Linked to Fat Enzyme in Liver Cells  이성욱 2010/10/15 2978
777   Sugars recruited in fight against persistent infections  이성욱 2011/05/17 2965
776   Gene Therapy Appears to Help Patient With Anemia  이성욱 2010/09/17 2963
  Viruses in the gut protect from infection  이성욱 2013/05/22 2946
774   Molecular scalpel hope for Duchenne muscular dystrophyBy James Gallagher  이성욱 2011/07/28 2942
773   Pluripotency not required !!!  이성욱 2010/01/28 2939
772   Autistic Mice Act a Lot Like Human Patients: Geneticists Develop Promising Mouse Model for Testing New Autism Therapies  이성욱 2011/10/06 2934
771   C형간염 진단 유전자검사 개발  이성욱 2013/03/07 2922
770   Why brain tumors hard to treat  이성욱 2010/11/23 2922
769   줄기세포 이식으로 HIV 감염 완치: 세계 3번째, 4번째의 HIV 완치 환자 등장  이성욱 2013/07/05 2910
768   More support for RNAi in clinic  이성욱 2010/03/23 2907

[이전 10개] [1]..[21][22][23][24] 25 [26][27][28][29][30]..[64] [다음 10개]
 

Copyright 1999-2024 Zeroboard / skin by ROBIN